This inventor holds 3 USPTO granted patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2013
Title: Catherine Defrenne: Innovator in Polypeptide Technologies
Introduction
Catherine Defrenne is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and polynucleotides. With a total of 3 patents to her name, her work has implications for diagnostic, prophylactic, and therapeutic applications.
Latest Patents
Catherine's latest patents include innovations related to BASB082, BASB083, BASB091, BASB092, and BASB101 polypeptides. These inventions provide methods for producing such polypeptides through recombinant techniques. Additionally, the patents detail the diagnostic, prophylactic, and therapeutic uses of these polypeptides and their corresponding polynucleotides.
Career Highlights
Catherine Defrenne is associated with GlaxoSmithKline Biologicals SA, where she has been instrumental in advancing research in her field. Her expertise in polypeptide technologies has positioned her as a key figure in the biotechnology sector.
Collaborations
Catherine has collaborated with notable colleagues, including Christine Delmelle and Jean-Louis Ruelle, contributing to a dynamic research environment that fosters innovation.
Conclusion
Catherine Defrenne's work in polypeptide technologies exemplifies the impact of innovative research in biotechnology. Her contributions continue to influence the development of therapeutic solutions in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile